{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:57:46Z","timestamp":1773421066422,"version":"3.50.1"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225197","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T18:45:27Z","timestamp":1573757127000},"page":"e0225197","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-6160","authenticated-orcid":true,"given":"Rafaela Borge","family":"Loureiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethel Leonor Noia","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Lyrio","family":"Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geisa","family":"Fregona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan E.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ueleres","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"2","key":"pone.0225197.ref001","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/0003-4819-122-2-199501150-00002","article-title":"Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers","volume":"122","author":"SA Maloney","year":"1995","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0225197.ref002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1164\/ajrccm.154.3.8810591","article-title":"The association between occupation and tuberculosis. A population-based survey","volume":"154","author":"MT McKenna","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0225197.ref003","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinids\/21.5.1098","article-title":"Tuberculosis among urban health care workers: a study using restriction fragment length polymorphism typing","volume":"21","author":"KA Sepkowitz","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"No. RR-17","key":"pone.0225197.ref004","first-page":"1","article-title":"Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings","volume":"54","author":"CDC","year":"2005","journal-title":"MMWR"},{"key":"pone.0225197.ref005","volume-title":"Global tuberculosis report 2018","author":"WHO","year":"2019"},{"issue":"22","key":"pone.0225197.ref006","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1001\/jama.293.22.2767","article-title":"Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally","volume":"293","author":"C Dye","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"pone.0225197.ref007","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling","volume":"13","author":"RM Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"9829","key":"pone.0225197.ref008","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":"Scaling up interventions to achieve global tuberculosis control: progress and new developments","volume":"379","author":"M Raviglione","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"pone.0225197.ref009","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"A Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0225197.ref010","first-page":"1","article-title":"O controle da tuberculose no Brasil: avan\u00e7os, inova\u00e7\u00f5es e desafios","volume":"44","author":"B Sa\u00fade","year":"2014","journal-title":"Boletim Epidemiol\u00f3gico"},{"key":"pone.0225197.ref011","unstructured":"Transmiss\u00edveis, B, Sa\u00fade Md, Sa\u00fade SdVe, Doen\u00e7as DdVd. Brasil Livre da Tuberculose: Plano Nacional pelo Fim da Tuberculose como Problema de Sa\u00fade P\u00fablica. Brasilia2017. 52 p p."},{"issue":"9","key":"pone.0225197.ref012","first-page":"1","article-title":"Brasil Livre da Tuberculose: evolu\u00e7\u00e3o dos cen\u00e1rios epidemiol\u00f3gicos e operacionais da doen\u00e7a","volume":"50","author":"BRASIL","year":"2019","journal-title":"Boletim Epidemiol\u00f3gico"},{"issue":"10","key":"pone.0225197.ref013","first-page":"1018","article-title":"III Brazilian Thoracic Association Guidelines on tuberculosis","volume":"35","author":"MB Conde","year":"2009","journal-title":"J Bras Pneumol"},{"key":"pone.0225197.ref014","volume-title":"WHO policy on TB infection control in health-care facilities, congregate settings and households","author":"WHO","year":"2009"},{"issue":"1","key":"pone.0225197.ref015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/rccm.2404004","article-title":"Diagnosing latent tuberculosis infection: turning glitter to gold","volume":"170","author":"PF Barnes","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0225197.ref016","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"RE Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0225197.ref017","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"D Menzies","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0225197.ref018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1086\/426434","article-title":"Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?","volume":"40","author":"F Tissot","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0225197.ref019","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"D Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"issue":"9235","key":"pone.0225197.ref020","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"P Andersen","year":"2000","journal-title":"Lancet"},{"issue":"12","key":"pone.0225197.ref021","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1086\/345760","article-title":"Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii","volume":"186","author":"SM Arend","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0225197.ref022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection","volume":"172","author":"G Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"9519","key":"pone.0225197.ref023","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"G Ferrara","year":"2006","journal-title":"Lancet"},{"key":"pone.0225197.ref024","volume-title":"Use of interferon-gamma release assays in support of TB diagnosis","author":"Control ECfDPa","year":"2011"},{"key":"pone.0225197.ref025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"A Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"4","key":"pone.0225197.ref026","doi-asserted-by":"crossref","first-page":"e59546","DOI":"10.1371\/journal.pone.0059546","article-title":"Cost-effectiveness of Quantiferon(R)-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil","volume":"8","author":"RE Steffen","year":"2013","journal-title":"PLoS One"},{"key":"pone.0225197.ref027","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1472-6963-11-247","article-title":"Systematic review of cost and cost-effectiveness of different TB-screening strategies","volume":"11","author":"A Nienhaus","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"pone.0225197.ref028","unstructured":"UK NCCfCC, NICE CfCPa. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. London2011."},{"issue":"6","key":"pone.0225197.ref029","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1469-0691.2011.03555.x","article-title":"Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion?","volume":"17","author":"CM Denkinger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"pone.0225197.ref030","unstructured":"BRASIL, Sa\u00fade Md, Sa\u00fade SdVe, Vigil\u00e2ncia Dd. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. Brasilia2011. 284 p p."},{"issue":"5","key":"pone.0225197.ref031","first-page":"551","article-title":"Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment","volume":"14","author":"A Trajman","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"pone.0225197.ref032","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis","volume":"60","author":"Prophylaxis IUATCo","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"3","key":"pone.0225197.ref033","first-page":"371","article-title":"BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life","volume":"46","author":"COMMITTEE TVCT","year":"1972","journal-title":"Bull World Health Organ"},{"issue":"2","key":"pone.0225197.ref034","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"E Vynnycky","year":"1997","journal-title":"Epidemiol Infect"},{"issue":"3","key":"pone.0225197.ref035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"M Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0225197.ref036","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/thx.2010.143180","article-title":"Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review","volume":"67","author":"A Zwerling","year":"2012","journal-title":"Thorax"},{"issue":"1","key":"pone.0225197.ref037","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"R Diel","year":"2011","journal-title":"Eur Respir J"},{"issue":"4","key":"pone.0225197.ref038","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1378\/chest.08-2048","article-title":"Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis","volume":"135","author":"R Diel","year":"2009","journal-title":"Chest"},{"issue":"4","key":"pone.0225197.ref039","first-page":"952","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"R Diel","year":"2010","journal-title":"ChestEpub 2009"},{"issue":"8","key":"pone.0225197.ref040","first-page":"66","article-title":"Activity-based analyses lead to better decision making","volume":"52","author":"S. Player","year":"1998","journal-title":"Healthc Financ Manage"},{"issue":"23","key":"pone.0225197.ref041","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","article-title":"Clinical practice. Latent tuberculosis infection","volume":"347","author":"RM Jasmer","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0225197.ref042","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of isoniazid for latent tuberculosis infection in a public health clinic","volume":"168","author":"PA LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0225197.ref043","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"CR Horsburgh","year":"2010","journal-title":"Chest"},{"issue":"23","key":"pone.0225197.ref044","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMsa021099","article-title":"Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States","volume":"347","author":"K Khan","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0225197.ref045","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?","volume":"3","author":"GW Comstock","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"pone.0225197.ref046","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic","volume":"281","author":"CM Nolan","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"pone.0225197.ref047","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and rifampin. A meta-analysis","volume":"99","author":"MA Steele","year":"1991","journal-title":"Chest"},{"issue":"1","key":"pone.0225197.ref048","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"FF Fountain","year":"2005","journal-title":"Chest"},{"issue":"8","key":"pone.0225197.ref049","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"JJ Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0225197.ref050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"BP Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"pone.0225197.ref051","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1183\/09031936.00079310","article-title":"Treatment of latent infection with Mycobacterium tuberculosis: update 2010","volume":"37","author":"CC Leung","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"pone.0225197.ref052","first-page":"486","article-title":"Isoniazid-related fatal hepatitis","volume":"164","author":"PS Millard","year":"1996","journal-title":"West J Med"},{"issue":"12","key":"pone.0225197.ref053","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","article-title":"Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis","volume":"127","author":"SR Salpeter","year":"1997","journal-title":"Ann Intern Med"},{"key":"pone.0225197.ref054","unstructured":"Canada, C, Health Mo, Diseases CfC, Control I, of PHA. Canadian Tuberculosis Standards, 7th Edition2014. 468 p p."},{"issue":"5","key":"pone.0225197.ref055","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"R Diel","year":"2007","journal-title":"Chest"},{"issue":"1","key":"pone.0225197.ref056","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1183\/09031936.06.00016906","article-title":"Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection","volume":"28","author":"JY Lee","year":"2006","journal-title":"Eur Respir J"},{"issue":"11","key":"pone.0225197.ref057","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"N Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 4","key":"pone.0225197.ref058","doi-asserted-by":"crossref","first-page":"S1120","DOI":"10.1093\/infdis\/jir410","article-title":"Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis","volume":"204","author":"JZ Metcalfe","year":"2011","journal-title":"J Infect Dis"},{"key":"pone.0225197.ref059","unstructured":"BRASIL, Sa\u00fade Md, Secretaria de Ci\u00eancia TeIE, Tecnologia DdCe. Diretrizes Metodol\u00f3gicas Estudos de Avalia\u00e7\u00e3o Econ\u00f4mica de Tecnologias em Sa\u00fade. Brasilia2009. 150 p p."},{"issue":"9","key":"pone.0225197.ref060","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5588\/ijtld.10.0542","article-title":"Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis","volume":"15","author":"JD Mancuso","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"pone.0225197.ref061","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhin.2014.10.002","article-title":"Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries","volume":"89","author":"A Kowada","year":"2015","journal-title":"J Hosp Infect"},{"issue":"12","key":"pone.0225197.ref062","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"F Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"pone.0225197.ref063","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"MA de Perio","year":"2009","journal-title":"Arch Intern Med"},{"issue":"RR-2","key":"pone.0225197.ref064","first-page":"15","article-title":"Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention","volume":"52","author":"CDC","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"ACS-6","key":"pone.0225197.ref065","first-page":"1","article-title":"Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS)","volume":"34","author":"C. Canadian Tuberculosis","year":"2008","journal-title":"Can Commun Dis Rep"},{"issue":"ACS-5","key":"pone.0225197.ref066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v36i00a05","article-title":"Recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS)\u20142010 Update","volume":"36","author":"C. Canadian Tuberculosis","year":"2010","journal-title":"Can Commun Dis Rep"},{"issue":"4","key":"pone.0225197.ref067","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"S Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"pone.0225197.ref068","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00408-009-9182-2","article-title":"The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis","volume":"187","author":"BD Fox","year":"2009","journal-title":"Lung"},{"issue":"No. RR-06","key":"pone.0225197.ref069","first-page":"1","article-title":"Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection","volume":"49","author":"CDC","year":"2000","journal-title":"MMWR"},{"issue":"5","key":"pone.0225197.ref070","first-page":"377","article-title":"Increased risk of Mycobacterium tuberculosis infection related to the occupational exposures of health care workers in Chiang Rai, Thailand","volume":"3","author":"AN Do","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"pone.0225197.ref071","first-page":"583","article-title":"Tuberculous infection in student nurses in Madrid, Spain","volume":"5","author":"J Esteban","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"pone.0225197.ref072","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/501869","article-title":"Factors associated with tuberculin reactivity in two general hospitals in Mexico","volume":"22","author":"ML Garcia-Garcia","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"pone.0225197.ref073","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/504358","article-title":"Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers","volume":"27","author":"N Harada","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"pone.0225197.ref074","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00420-007-0212-1","article-title":"Evaluation of the interferon-gamma release assay in healthcare workers","volume":"81","author":"A Nienhaus","year":"2008","journal-title":"Int Arch Occup Environ Health"},{"issue":"2\u20133","key":"pone.0225197.ref075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7883\/yoken.JJID.2007.102","article-title":"Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey","volume":"60","author":"D Ozdemir","year":"2007","journal-title":"Jpn J Infect Dis"},{"issue":"22","key":"pone.0225197.ref076","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1001\/jama.293.22.2746","article-title":"Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing","volume":"293","author":"M Pai","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"pone.0225197.ref077","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"M Pai","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0225197.ref078","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/590262","article-title":"Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?","volume":"29","author":"NR Pollock","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"pone.0225197.ref079","first-page":"1335","article-title":"A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals","volume":"9","author":"VR Roth","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"pone.0225197.ref080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/501975","article-title":"Tuberculin skin testing among healthcare workers in the University of Malaya Medical Centre, Kuala Lumpur, Malaysia","volume":"23","author":"LH Tan","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"pone.0225197.ref081","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1164\/rccm.2306004","article-title":"Isoniazid for latent tuberculosis infection: approaching 40 and reaching its prime","volume":"168","author":"CM Nolan","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"9777","key":"pone.0225197.ref082","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"T Samandari","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"pone.0225197.ref083","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","author":"M Pai","year":"2007","journal-title":"PLoS Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:10:53Z","timestamp":1722035453000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225197"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":83,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225197","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}